- United Kingdom
- /
- Aerospace & Defense
- /
- LSE:AVON
Are Investors Undervaluing Avon Protection plc (LON:AVON) By 32%?
Key Insights
- The projected fair value for Avon Protection is UK£9.70 based on 2 Stage Free Cash Flow to Equity
- Avon Protection is estimated to be 32% undervalued based on current share price of UK£6.55
- The US$9.66 analyst price target for AVONis comparable to our estimate of fair value.
Does the October share price for Avon Protection plc (LON:AVON) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the forecast future cash flows of the company and discounting them back to today's value. Our analysis will employ the Discounted Cash Flow (DCF) model. There's really not all that much to it, even though it might appear quite complex.
We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.
See our latest analysis for Avon Protection
The Method
We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate:
10-year free cash flow (FCF) estimate
2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | |
Levered FCF ($, Millions) | US$16.0m | US$18.1m | US$18.7m | US$19.7m | US$20.7m | US$21.4m | US$22.0m | US$22.6m | US$23.1m | US$23.5m |
Growth Rate Estimate Source | Analyst x3 | Analyst x3 | Analyst x1 | Analyst x1 | Analyst x1 | Est @ 3.57% | Est @ 2.91% | Est @ 2.45% | Est @ 2.13% | Est @ 1.91% |
Present Value ($, Millions) Discounted @ 7.0% | US$14.9 | US$15.8 | US$15.2 | US$15.0 | US$14.7 | US$14.3 | US$13.7 | US$13.1 | US$12.6 | US$12.0 |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = US$141m
We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 1.4%. We discount the terminal cash flows to today's value at a cost of equity of 7.0%.
Terminal Value (TV)= FCF2033 × (1 + g) ÷ (r – g) = US$23m× (1 + 1.4%) ÷ (7.0%– 1.4%) = US$425m
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= US$425m÷ ( 1 + 7.0%)10= US$216m
The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is US$358m. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Relative to the current share price of UK£6.6, the company appears quite undervalued at a 32% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out.
Important Assumptions
We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Avon Protection as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 7.0%, which is based on a levered beta of 0.949. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for Avon Protection
- Debt is well covered by cash flow.
- Interest payments on debt are not well covered.
- Dividend is low compared to the top 25% of dividend payers in the Aerospace & Defense market.
- Annual earnings are forecast to grow faster than the British market.
- Trading below our estimate of fair value by more than 20%.
- Dividends are not covered by earnings and cashflows.
- Annual revenue is expected to decline over the next 3 years.
Next Steps:
Valuation is only one side of the coin in terms of building your investment thesis, and it is only one of many factors that you need to assess for a company. DCF models are not the be-all and end-all of investment valuation. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. What is the reason for the share price sitting below the intrinsic value? For Avon Protection, there are three further elements you should assess:
- Risks: For instance, we've identified 2 warning signs for Avon Protection (1 makes us a bit uncomfortable) you should be aware of.
- Future Earnings: How does AVON's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
- Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the LSE every day. If you want to find the calculation for other stocks just search here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About LSE:AVON
Avon Technologies
Provides respiratory and head protection products for the military and first responder markets in Europe and the United States.
Excellent balance sheet with reasonable growth potential.